Search research articles
Contact Us
Filters
Showing results (211-220 of 292) with videos related to
Page
of 30
Sort By:
International Urology and Nephrology
|
April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
Katharina Möller, Christoph Fraune, Niclas C Blessin, et al.
European Urology Open Science
|
August 2, 2021
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
Tom-Régis Dobé, Gianluigi Califano, Friedrich-Carl von Rundstedt, et al.
World Journal of Urology
|
May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma
Georgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
BJU International
|
August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis
Ekaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
International Urology and Nephrology
|
December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Urologic Oncology
|
August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study
Romain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Urologia Internationalis
|
July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma
Georgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
European Urology
|
January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification
Shahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
BMC Urology
|
February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis
Henning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Page
of 30
Search research articles
Search
Showing results (211-220 of 292) with videos related to
Sort By:
Page
of 30
International Urology and Nephrology
|
April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
Katharina Möller, Christoph Fraune, Niclas C Blessin, et al.
European Urology Open Science
|
August 2, 2021
Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
Tom-Régis Dobé, Gianluigi Califano, Friedrich-Carl von Rundstedt, et al.
World Journal of Urology
|
May 19, 2015
Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma
Georgios Gakis, Todd M Morgan, Jason A Efstathiou, et al.
BJU International
|
August 10, 2023
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis
Ekaterina Laukhtina, Markus von Deimling, Benjamin Pradere, et al.
International Urology and Nephrology
|
December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Urologic Oncology
|
August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study
Romain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
European Urology
|
March 21, 2025
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
Antoine G van der Heijden, Harman Max Bruins, Albert Carrion, et al.
Urologia Internationalis
|
July 28, 2016
Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma
Georgios Gakis, Jason A Efstathiou, Siamak Daneshmand, et al.
European Urology
|
January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification
Shahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
BMC Urology
|
February 20, 2025
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis
Henning Plage, Adrian Frericks, Sebastian Hofbauer, et al.
Page
of 30